# Burning Rock Biotech Ltd: financial statements, quarterly

BNR · Nasdaq · CIK 1792267 · [Healthcare](/sectors/healthcare.md)

Pages: [Overview](/companies/bnr.md) · [Financials](/companies/bnr/financials.md) · [Filings](/companies/bnr/filings.md) · [Insiders](/companies/bnr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bnr/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [290](/filings/0001193125-21-090543.md) | [225](/filings/0001193125-22-133522.md) | [131](/filings/0001193125-23-108289.md) | [86.6](/filings/0001193125-24-119655.md) | [71.2](/filings/0001193125-25-101753.md) | [68.4](/filings/0001193125-26-183377.md) |
| Current assets | $m | [387](/filings/0001193125-21-090543.md) | [286](/filings/0001193125-22-133522.md) | [183](/filings/0001193125-23-108289.md) | [125](/filings/0001193125-24-119655.md) | [106](/filings/0001193125-25-101753.md) | [106](/filings/0001193125-26-183377.md) |
| Total assets | $m | [408](/filings/0001193125-21-090543.md) | [358](/filings/0001193125-22-133522.md) | [230](/filings/0001193125-23-108289.md) | [146](/filings/0001193125-24-119655.md) | [121](/filings/0001193125-25-101753.md) | [117](/filings/0001193125-26-183377.md) |
| Current liabilities | $m | [37.0](/filings/0001193125-21-090543.md) | [58.4](/filings/0001193125-22-133522.md) | [59.7](/filings/0001193125-23-108289.md) | [37.1](/filings/0001193125-24-119655.md) | [36.5](/filings/0001193125-25-101753.md) | [35.3](/filings/0001193125-26-183377.md) |
| Total liabilities | $m | [37.1](/filings/0001193125-21-090543.md) | [68.0](/filings/0001193125-22-133522.md) | [62.2](/filings/0001193125-23-108289.md) | [38.3](/filings/0001193125-24-119655.md) | [41.7](/filings/0001193125-25-101753.md) | [40.8](/filings/0001193125-26-183377.md) |
| Current portion of debt | $m | [3.3](/filings/0001193125-22-133522.md) | [0.0](/filings/0001193125-22-133522.md) | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [1.1](/filings/0001193125-21-090543.md) | [0.4](/filings/0001193125-22-133522.md) | [0.0](/filings/0001193125-23-108289.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [371](/filings/0001193125-21-090543.md) | [290](/filings/0001193125-22-133522.md) | [168](/filings/0001193125-23-108289.md) | [108](/filings/0001193125-24-119655.md) | [79.6](/filings/0001193125-25-101753.md) | [76.5](/filings/0001193125-26-183377.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.